COGSTATE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.232 AUD | -1.40% |
|
-1.40% | -14.71% |
| 01/04 | Cogstate Amends License Agreement with Eisai for Alzheimer’s Treatment | MT |
| 22/02 | Cogstate's Fiscal H1 Attributable Profit Jumps, Revenue Rises 3%; Shares Decline 8% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 14Cr | ||||||
| 6.26TCr | - | |||||
| 4.12TCr | ||||||
| 4.03TCr | ||||||
| 2.79TCr | ||||||
| 2.62TCr |
- Stock Market
- Equities
- CGS Stock
- Charts Cogstate Limited
- Sector Chart
